#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=2 .
1-1	0-1	2	quantity	new	_	_
1-2	2-3	.	_	_	_	_

#Text=The Mechanism of Action
2-1	4-7	The	event[2]	new[2]	_	_
2-2	8-17	Mechanism	event[2]	new[2]	_	_
2-3	18-20	of	event[2]	new[2]	_	_
2-4	21-27	Action	event[2]|abstract	new[2]|new	_	_

#Text=Only Lucilia sericata larvae from certified farms can be safely used in medicine .
3-1	28-32	Only	_	_	_	_
3-2	33-40	Lucilia	_	_	_	_
3-3	41-49	sericata	animal[4]	new[4]	coref	7-4[0_4]
3-4	50-56	larvae	animal[4]	new[4]	_	_
3-5	57-61	from	animal[4]	new[4]	_	_
3-6	62-71	certified	animal[4]|place[5]	new[4]|new[5]	_	_
3-7	72-77	farms	animal[4]|place[5]	new[4]|new[5]	_	_
3-8	78-81	can	_	_	_	_
3-9	82-84	be	_	_	_	_
3-10	85-91	safely	_	_	_	_
3-11	92-96	used	_	_	_	_
3-12	97-99	in	_	_	_	_
3-13	100-108	medicine	substance	new	_	_
3-14	109-110	.	_	_	_	_

#Text=Complicated procedures of egg disinfection , using chloroamine , povidone-iodine and sodium hypochlorite , are intended to ensure safety during use of this product .
4-1	111-122	Complicated	abstract[7]	new[7]	_	_
4-2	123-133	procedures	abstract[7]	new[7]	_	_
4-3	134-136	of	abstract[7]	new[7]	_	_
4-4	137-140	egg	abstract[7]|object|abstract[9]	new[7]|new|new[9]	_	_
4-5	141-153	disinfection	abstract[7]|abstract[9]	new[7]|new[9]	_	_
4-6	154-155	,	_	_	_	_
4-7	156-161	using	_	_	_	_
4-8	162-173	chloroamine	substance	new	_	_
4-9	174-175	,	_	_	_	_
4-10	176-191	povidone-iodine	substance	new	_	_
4-11	192-195	and	_	_	_	_
4-12	196-202	sodium	substance|substance[13]	new|new[13]	_	_
4-13	203-215	hypochlorite	substance[13]	new[13]	_	_
4-14	216-217	,	_	_	_	_
4-15	218-221	are	_	_	_	_
4-16	222-230	intended	_	_	_	_
4-17	231-233	to	_	_	_	_
4-18	234-240	ensure	_	_	_	_
4-19	241-247	safety	abstract	new	_	_
4-20	248-254	during	_	_	_	_
4-21	255-258	use	abstract[15]	new[15]	_	_
4-22	259-261	of	abstract[15]	new[15]	_	_
4-23	262-266	this	abstract[15]|substance[16]	new[15]|new[16]	_	_
4-24	267-274	product	abstract[15]|substance[16]	new[15]|new[16]	_	_
4-25	275-276	.	_	_	_	_

#Text=MDT is based on three mechanisms , observed when Lucilia sericata are introduced to the wound : the mechanical removal of necrotic tissue , bactericidal and bacteriostatic activity , and promotion of the healing process .
5-1	277-280	MDT	event	new	_	_
5-2	281-283	is	_	_	_	_
5-3	284-289	based	_	_	_	_
5-4	290-292	on	_	_	_	_
5-5	293-298	three	abstract[18]	new[18]	_	_
5-6	299-309	mechanisms	abstract[18]	new[18]	_	_
5-7	310-311	,	_	_	_	_
5-8	312-320	observed	_	_	_	_
5-9	321-325	when	_	_	_	_
5-10	326-333	Lucilia	_	_	_	_
5-11	334-342	sericata	_	_	_	_
5-12	343-346	are	_	_	_	_
5-13	347-357	introduced	_	_	_	_
5-14	358-360	to	_	_	_	_
5-15	361-364	the	abstract[19]	new[19]	coref	6-12[29_19]
5-16	365-370	wound	abstract[19]	new[19]	_	_
5-17	371-372	:	_	_	_	_
5-18	373-376	the	event[20]	new[20]	_	_
5-19	377-387	mechanical	event[20]	new[20]	_	_
5-20	388-395	removal	event[20]	new[20]	_	_
5-21	396-398	of	event[20]	new[20]	_	_
5-22	399-407	necrotic	event[20]|object[21]	new[20]|new[21]	coref	13-9[0_21]
5-23	408-414	tissue	event[20]|object[21]	new[20]|new[21]	_	_
5-24	415-416	,	event[20]	new[20]	_	_
5-25	417-429	bactericidal	event[20]	new[20]	_	_
5-26	430-433	and	event[20]	new[20]	_	_
5-27	434-448	bacteriostatic	event[20]|abstract[22]	new[20]|new[22]	_	_
5-28	449-457	activity	event[20]|abstract[22]	new[20]|new[22]	_	_
5-29	458-459	,	_	_	_	_
5-30	460-463	and	_	_	_	_
5-31	464-473	promotion	event[23]	new[23]	_	_
5-32	474-476	of	event[23]	new[23]	_	_
5-33	477-480	the	event[23]|abstract[25]	new[23]|new[25]	coref	7-6[38_25]
5-34	481-488	healing	event[23]|object|abstract[25]	new[23]|new|new[25]	coref	12-11
5-35	489-496	process	event[23]|abstract[25]	new[23]|new[25]	_	_
5-36	497-498	.	_	_	_	_

#Text=Reports from the last decade point out that physical contact with the wound is a less important effect of the larval presence within the wound , and is probably a negative effect for the patient , who may feel a physical presence and wiggling in the wound .
6-1	499-506	Reports	abstract[26]	new[26]	_	_
6-2	507-511	from	abstract[26]	new[26]	_	_
6-3	512-515	the	abstract[26]	new[26]	_	_
6-4	516-520	last	abstract[26]	new[26]	_	_
6-5	521-527	decade	abstract[26]|time	new[26]|new	_	_
6-6	528-533	point	abstract[26]	new[26]	_	_
6-7	534-537	out	_	_	_	_
6-8	538-542	that	_	_	_	_
6-9	543-551	physical	abstract[28]	new[28]	coref	6-15[30_28]
6-10	552-559	contact	abstract[28]	new[28]	_	_
6-11	560-564	with	abstract[28]	new[28]	_	_
6-12	565-568	the	abstract[28]|abstract[29]	new[28]|giv[29]	coref	6-24[32_29]
6-13	569-574	wound	abstract[28]|abstract[29]	new[28]|giv[29]	_	_
6-14	575-577	is	_	_	_	_
6-15	578-579	a	abstract[30]	giv[30]	_	_
6-16	580-584	less	abstract[30]	giv[30]	_	_
6-17	585-594	important	abstract[30]	giv[30]	_	_
6-18	595-601	effect	abstract[30]	giv[30]	_	_
6-19	602-604	of	abstract[30]	giv[30]	_	_
6-20	605-608	the	abstract[30]|abstract[31]	giv[30]|new[31]	coref	6-40[34_31]
6-21	609-615	larval	abstract[30]|abstract[31]	giv[30]|new[31]	_	_
6-22	616-624	presence	abstract[30]|abstract[31]	giv[30]|new[31]	_	_
6-23	625-631	within	abstract[30]|abstract[31]	giv[30]|new[31]	_	_
6-24	632-635	the	abstract[30]|abstract[31]|abstract[32]	giv[30]|new[31]|giv[32]	coref	6-46[35_32]
6-25	636-641	wound	abstract[30]|abstract[31]|abstract[32]	giv[30]|new[31]|giv[32]	_	_
6-26	642-643	,	abstract[30]	giv[30]	_	_
6-27	644-647	and	abstract[30]	giv[30]	_	_
6-28	648-650	is	abstract[30]	giv[30]	_	_
6-29	651-659	probably	abstract[30]	giv[30]	_	_
6-30	660-661	a	abstract[30]	giv[30]	_	_
6-31	662-670	negative	abstract[30]	giv[30]	_	_
6-32	671-677	effect	abstract[30]	giv[30]	_	_
6-33	678-681	for	abstract[30]	giv[30]	_	_
6-34	682-685	the	abstract[30]|person[33]	giv[30]|new[33]	_	_
6-35	686-693	patient	abstract[30]|person[33]	giv[30]|new[33]	_	_
6-36	694-695	,	_	_	_	_
6-37	696-699	who	_	_	_	_
6-38	700-703	may	_	_	_	_
6-39	704-708	feel	_	_	_	_
6-40	709-710	a	abstract[34]	giv[34]	_	_
6-41	711-719	physical	abstract[34]	giv[34]	_	_
6-42	720-728	presence	abstract[34]	giv[34]	_	_
6-43	729-732	and	_	_	_	_
6-44	733-741	wiggling	_	_	_	_
6-45	742-744	in	_	_	_	_
6-46	745-748	the	abstract[35]	giv[35]	coref	7-15[0_35]
6-47	749-754	wound	abstract[35]	giv[35]	_	_
6-48	755-756	.	_	_	_	_

#Text=Chemicals secreted by larvae initiate the process of bacterial elimination and remodeling of the wound bed .
7-1	757-766	Chemicals	substance	new	_	_
7-2	767-775	secreted	_	_	_	_
7-3	776-778	by	_	_	_	_
7-4	779-785	larvae	animal	giv	coref	10-5[51_0]
7-5	786-794	initiate	_	_	_	_
7-6	795-798	the	abstract[38]	giv[38]	coref	12-8[70_38]
7-7	799-806	process	abstract[38]	giv[38]	_	_
7-8	807-809	of	abstract[38]	giv[38]	_	_
7-9	810-819	bacterial	abstract[38]|substance|event[40]	giv[38]|new|new[40]	_	_
7-10	820-831	elimination	abstract[38]|event[40]	giv[38]|new[40]	_	_
7-11	832-835	and	abstract[38]	giv[38]	_	_
7-12	836-846	remodeling	abstract[38]|abstract[41]	giv[38]|new[41]	_	_
7-13	847-849	of	abstract[38]|abstract[41]	giv[38]|new[41]	_	_
7-14	850-853	the	abstract[38]|abstract[41]|object[43]	giv[38]|new[41]|new[43]	coref	14-5[82_43]
7-15	854-859	wound	abstract[38]|abstract[41]|abstract|object[43]	giv[38]|new[41]|giv|new[43]	coref	9-7[48_0]
7-16	860-863	bed	abstract[38]|abstract[41]|object[43]	giv[38]|new[41]|new[43]	_	_
7-17	864-865	.	_	_	_	_

#Text=Figure 1
8-1	866-872	Figure	object[44]	new[44]	_	_
8-2	873-874	1	object[44]	new[44]	_	_

#Text=shows the effect of debridement on a necrotic forearm wound measuring over 200 cm² .
9-1	875-880	shows	_	_	_	_
9-2	881-884	the	abstract[45]	new[45]	_	_
9-3	885-891	effect	abstract[45]	new[45]	_	_
9-4	892-894	of	abstract[45]	new[45]	_	_
9-5	895-906	debridement	abstract[45]|event	new[45]|new	coref	18-14
9-6	907-909	on	_	_	_	_
9-7	910-911	a	abstract[48]	giv[48]	coref	10-15[54_48]
9-8	912-920	necrotic	abstract[48]	giv[48]	_	_
9-9	921-928	forearm	object|abstract[48]	new|giv[48]	coref	10-21
9-10	929-934	wound	abstract[48]	giv[48]	_	_
9-11	935-944	measuring	_	_	_	_
9-12	945-949	over	quantity[49]	new[49]	_	_
9-13	950-953	200	quantity[49]	new[49]	_	_
9-14	954-957	cm²	quantity[49]	new[49]	_	_
9-15	958-959	.	_	_	_	_

#Text=Within 72 hours , 100 free-range larvae cleansed over 70 % of necrosis in the wound , revealing the damaged forearm bones .
10-1	960-966	Within	_	_	_	_
10-2	967-969	72	time[50]	new[50]	_	_
10-3	970-975	hours	time[50]	new[50]	_	_
10-4	976-977	,	_	_	_	_
10-5	978-981	100	animal[51]	giv[51]	coref	17-17[99_51]
10-6	982-992	free-range	animal[51]	giv[51]	_	_
10-7	993-999	larvae	animal[51]	giv[51]	_	_
10-8	1000-1008	cleansed	_	_	_	_
10-9	1009-1013	over	quantity[52]	new[52]	_	_
10-10	1014-1016	70	quantity[52]	new[52]	_	_
10-11	1017-1018	%	quantity[52]	new[52]	_	_
10-12	1019-1021	of	quantity[52]	new[52]	_	_
10-13	1022-1030	necrosis	quantity[52]|abstract	new[52]|new	coref	11-24
10-14	1031-1033	in	_	_	_	_
10-15	1034-1037	the	abstract[54]	giv[54]	coref	12-10[0_54]
10-16	1038-1043	wound	abstract[54]	giv[54]	_	_
10-17	1044-1045	,	_	_	_	_
10-18	1046-1055	revealing	_	_	_	_
10-19	1056-1059	the	object[56]	new[56]	_	_
10-20	1060-1067	damaged	object[56]	new[56]	_	_
10-21	1068-1075	forearm	object|object[56]	giv|new[56]	_	_
10-22	1076-1081	bones	object[56]	new[56]	_	_
10-23	1082-1083	.	_	_	_	_

#Text=The above observations suggest the potential use of this method in cases where wounds cover full skin-thickness , with a high risk of necrosis , or an already existing infection .
11-1	1084-1087	The	abstract[57]	new[57]	_	_
11-2	1088-1093	above	abstract[57]	new[57]	_	_
11-3	1094-1106	observations	abstract[57]	new[57]	_	_
11-4	1107-1114	suggest	_	_	_	_
11-5	1115-1118	the	abstract[58]	new[58]	_	_
11-6	1119-1128	potential	abstract[58]	new[58]	_	_
11-7	1129-1132	use	abstract[58]	new[58]	_	_
11-8	1133-1135	of	abstract[58]	new[58]	_	_
11-9	1136-1140	this	abstract[58]|abstract[59]	new[58]|new[59]	coref	12-4[67_59]
11-10	1141-1147	method	abstract[58]|abstract[59]	new[58]|new[59]	_	_
11-11	1148-1150	in	abstract[58]|abstract[59]	new[58]|new[59]	_	_
11-12	1151-1156	cases	abstract[58]|abstract[59]|abstract	new[58]|new[59]|new	_	_
11-13	1157-1162	where	_	_	_	_
11-14	1163-1169	wounds	object	new	_	_
11-15	1170-1175	cover	_	_	_	_
11-16	1176-1180	full	quantity[62]	new[62]	_	_
11-17	1181-1195	skin-thickness	quantity[62]	new[62]	_	_
11-18	1196-1197	,	_	_	_	_
11-19	1198-1202	with	_	_	_	_
11-20	1203-1204	a	abstract[63]	new[63]	_	_
11-21	1205-1209	high	abstract[63]	new[63]	_	_
11-22	1210-1214	risk	abstract[63]	new[63]	_	_
11-23	1215-1217	of	abstract[63]	new[63]	_	_
11-24	1218-1226	necrosis	abstract[63]|event	new[63]|giv	coref	21-4
11-25	1227-1228	,	_	_	_	_
11-26	1229-1231	or	_	_	_	_
11-27	1232-1234	an	abstract[65]	new[65]	_	_
11-28	1235-1242	already	abstract[65]	new[65]	_	_
11-29	1243-1251	existing	abstract[65]	new[65]	_	_
11-30	1252-1261	infection	abstract[65]	new[65]	_	_
11-31	1262-1263	.	_	_	_	_

#Text=The selection of an appropriate method for the further wound healing process is the next stage of local action .
12-1	1264-1267	The	event[66]	new[66]	coref	12-14[71_66]
12-2	1268-1277	selection	event[66]	new[66]	_	_
12-3	1278-1280	of	event[66]	new[66]	_	_
12-4	1281-1283	an	event[66]|abstract[67]	new[66]|giv[67]	_	_
12-5	1284-1295	appropriate	event[66]|abstract[67]	new[66]|giv[67]	_	_
12-6	1296-1302	method	event[66]|abstract[67]	new[66]|giv[67]	_	_
12-7	1303-1306	for	event[66]|abstract[67]	new[66]|giv[67]	_	_
12-8	1307-1310	the	event[66]|abstract[67]|abstract[70]	new[66]|giv[67]|giv[70]	coref	18-13[105_70]
12-9	1311-1318	further	event[66]|abstract[67]|abstract[70]	new[66]|giv[67]|giv[70]	_	_
12-10	1319-1324	wound	event[66]|abstract[67]|abstract|abstract[70]	new[66]|giv[67]|giv|giv[70]	coref	14-6
12-11	1325-1332	healing	event[66]|abstract[67]|event|abstract[70]	new[66]|giv[67]|giv|giv[70]	coref	22-18
12-12	1333-1340	process	event[66]|abstract[67]|abstract[70]	new[66]|giv[67]|giv[70]	_	_
12-13	1341-1343	is	_	_	_	_
12-14	1344-1347	the	event[71]	giv[71]	_	_
12-15	1348-1352	next	event[71]	giv[71]	_	_
12-16	1353-1358	stage	event[71]	giv[71]	_	_
12-17	1359-1361	of	event[71]	giv[71]	_	_
12-18	1362-1367	local	event[71]|abstract[72]	giv[71]|new[72]	_	_
12-19	1368-1374	action	event[71]|abstract[72]	giv[71]|new[72]	_	_
12-20	1375-1376	.	_	_	_	_

#Text=A maggot does not literally consume pieces of tissue , but it secretes and excretes digestive enzymes ( digestive secretions and excretions of arginase ) .
13-1	1377-1378	A	animal[73]	new[73]	ana	13-12[0_73]
13-2	1379-1385	maggot	animal[73]	new[73]	_	_
13-3	1386-1390	does	_	_	_	_
13-4	1391-1394	not	_	_	_	_
13-5	1395-1404	literally	_	_	_	_
13-6	1405-1412	consume	_	_	_	_
13-7	1413-1419	pieces	object[74]	new[74]	_	_
13-8	1420-1422	of	object[74]	new[74]	_	_
13-9	1423-1429	tissue	object[74]|object	new[74]|giv	coref	15-1[85_0]
13-10	1430-1431	,	_	_	_	_
13-11	1432-1435	but	_	_	_	_
13-12	1436-1438	it	animal	giv	coref	14-11[83_0]
13-13	1439-1447	secretes	_	_	_	_
13-14	1448-1451	and	_	_	_	_
13-15	1452-1460	excretes	_	_	_	_
13-16	1461-1470	digestive	substance[77]	new[77]	appos	13-19[78_77]
13-17	1471-1478	enzymes	substance[77]	new[77]	_	_
13-18	1479-1480	(	_	_	_	_
13-19	1481-1490	digestive	substance[78]	giv[78]	coref	17-13[98_78]
13-20	1491-1501	secretions	substance[78]	giv[78]	_	_
13-21	1502-1505	and	substance[78]	giv[78]	_	_
13-22	1506-1516	excretions	substance[78]	giv[78]	_	_
13-23	1517-1519	of	substance[78]	giv[78]	_	_
13-24	1520-1528	arginase	substance[78]|substance	giv[78]|new	coref	18-9[103_0]
13-25	1529-1530	)	_	_	_	_
13-26	1531-1532	.	_	_	_	_

#Text=Digestion begins directly in the wound bed , outside the maggot ’s body .
14-1	1533-1542	Digestion	substance	new	_	_
14-2	1543-1549	begins	_	_	_	_
14-3	1550-1558	directly	_	_	_	_
14-4	1559-1561	in	_	_	_	_
14-5	1562-1565	the	place[82]	giv[82]	coref	23-23[142_82]
14-6	1566-1571	wound	abstract|place[82]	giv|giv[82]	coref	16-19[92_0]
14-7	1572-1575	bed	place[82]	giv[82]	_	_
14-8	1576-1577	,	_	_	_	_
14-9	1578-1585	outside	_	_	_	_
14-10	1586-1589	the	object[84]	new[84]	_	_
14-11	1590-1596	maggot	animal[83]|object[84]	giv[83]|new[84]	coref	15-11[86_83]
14-12	1597-1599	’s	animal[83]|object[84]	giv[83]|new[84]	_	_
14-13	1600-1604	body	object[84]	new[84]	_	_
14-14	1605-1606	.	_	_	_	_

#Text=Dead tissue is liquefied and can be easily absorbed by the maggot .
15-1	1607-1611	Dead	object[85]	giv[85]	coref	18-7[0_85]
15-2	1612-1618	tissue	object[85]	giv[85]	_	_
15-3	1619-1621	is	_	_	_	_
15-4	1622-1631	liquefied	_	_	_	_
15-5	1632-1635	and	_	_	_	_
15-6	1636-1639	can	_	_	_	_
15-7	1640-1642	be	_	_	_	_
15-8	1643-1649	easily	_	_	_	_
15-9	1650-1658	absorbed	_	_	_	_
15-10	1659-1661	by	_	_	_	_
15-11	1662-1665	the	animal[86]	giv[86]	_	_
15-12	1666-1672	maggot	animal[86]	giv[86]	_	_
15-13	1673-1674	.	_	_	_	_

#Text=This phenomenon can be easily observed during therapy because of the increase in the amount of exudate from the wound and its specific odor .
16-1	1675-1679	This	abstract[87]	new[87]	_	_
16-2	1680-1690	phenomenon	abstract[87]	new[87]	_	_
16-3	1691-1694	can	_	_	_	_
16-4	1695-1697	be	_	_	_	_
16-5	1698-1704	easily	_	_	_	_
16-6	1705-1713	observed	_	_	_	_
16-7	1714-1720	during	_	_	_	_
16-8	1721-1728	therapy	event[88]	new[88]	coref	36-4[252_88]
16-9	1729-1736	because	event[88]	new[88]	_	_
16-10	1737-1739	of	event[88]	new[88]	_	_
16-11	1740-1743	the	event[88]|abstract[89]	new[88]|new[89]	_	_
16-12	1744-1752	increase	event[88]|abstract[89]	new[88]|new[89]	_	_
16-13	1753-1755	in	event[88]|abstract[89]	new[88]|new[89]	_	_
16-14	1756-1759	the	event[88]|abstract[89]|quantity[90]	new[88]|new[89]|new[90]	_	_
16-15	1760-1766	amount	event[88]|abstract[89]|quantity[90]	new[88]|new[89]|new[90]	_	_
16-16	1767-1769	of	event[88]|abstract[89]|quantity[90]	new[88]|new[89]|new[90]	_	_
16-17	1770-1777	exudate	event[88]|abstract[89]|quantity[90]|abstract	new[88]|new[89]|new[90]|new	coref	36-19
16-18	1778-1782	from	event[88]|abstract[89]|quantity[90]	new[88]|new[89]|new[90]	_	_
16-19	1783-1786	the	event[88]|abstract[89]|quantity[90]|abstract[92]	new[88]|new[89]|new[90]|giv[92]	coref	20-7[114_92]
16-20	1787-1792	wound	event[88]|abstract[89]|quantity[90]|abstract[92]	new[88]|new[89]|new[90]|giv[92]	_	_
16-21	1793-1796	and	event[88]|abstract[89]|quantity[90]	new[88]|new[89]|new[90]	_	_
16-22	1797-1800	its	event[88]|abstract[89]|quantity[90]|abstract[93]	new[88]|new[89]|new[90]|new[93]	_	_
16-23	1801-1809	specific	event[88]|abstract[89]|quantity[90]|abstract[93]	new[88]|new[89]|new[90]|new[93]	_	_
16-24	1810-1814	odor	event[88]|abstract[89]|quantity[90]|abstract[93]	new[88]|new[89]|new[90]|new[93]	_	_
16-25	1815-1816	.	_	_	_	_

#Text=Hobson was the first scientist to systematically present the proteolytic effects of digestive enzymes produced by the larvae of Lucilia sericata .
17-1	1817-1823	Hobson	person	new	coref	17-3[95_0]
17-2	1824-1827	was	_	_	_	_
17-3	1828-1831	the	person[95]	giv[95]	_	_
17-4	1832-1837	first	person[95]	giv[95]	_	_
17-5	1838-1847	scientist	person[95]	giv[95]	_	_
17-6	1848-1850	to	_	_	_	_
17-7	1851-1865	systematically	_	_	_	_
17-8	1866-1873	present	_	_	_	_
17-9	1874-1877	the	abstract[96]	new[96]	_	_
17-10	1878-1889	proteolytic	abstract[96]	new[96]	_	_
17-11	1890-1897	effects	abstract[96]	new[96]	_	_
17-12	1898-1900	of	abstract[96]	new[96]	_	_
17-13	1901-1910	digestive	abstract[96]|abstract|substance[98]	new[96]|new|giv[98]	coref|coref	19-1[106_98]|19-1[106_98]
17-14	1911-1918	enzymes	abstract[96]|substance[98]	new[96]|giv[98]	_	_
17-15	1919-1927	produced	_	_	_	_
17-16	1928-1930	by	_	_	_	_
17-17	1931-1934	the	animal[99]	giv[99]	coref	25-23[166_99]
17-18	1935-1941	larvae	animal[99]	giv[99]	_	_
17-19	1942-1944	of	animal[99]	giv[99]	_	_
17-20	1945-1952	Lucilia	animal[99]	giv[99]	_	_
17-21	1953-1961	sericata	animal[99]	giv[99]	_	_
17-22	1962-1963	.	_	_	_	_

#Text=The movements of maggots , scratching tissue and secreting arginase , facilitate the debridement process .
18-1	1964-1967	The	abstract[100]	new[100]	_	_
18-2	1968-1977	movements	abstract[100]	new[100]	_	_
18-3	1978-1980	of	abstract[100]	new[100]	_	_
18-4	1981-1988	maggots	abstract[100]|animal	new[100]|new	coref	20-28[119_0]
18-5	1989-1990	,	abstract[100]	new[100]	_	_
18-6	1991-2001	scratching	abstract[100]	new[100]	_	_
18-7	2002-2008	tissue	abstract[100]|object	new[100]|giv	coref	20-13[116_0]
18-8	2009-2012	and	abstract[100]	new[100]	_	_
18-9	2013-2022	secreting	abstract[100]|substance[103]	new[100]|giv[103]	_	_
18-10	2023-2031	arginase	abstract[100]|substance[103]	new[100]|giv[103]	_	_
18-11	2032-2033	,	_	_	_	_
18-12	2034-2044	facilitate	_	_	_	_
18-13	2045-2048	the	abstract[105]	giv[105]	coref	21-11[125_105]
18-14	2049-2060	debridement	abstract|abstract[105]	giv|giv[105]	coref	31-2
18-15	2061-2068	process	abstract[105]	giv[105]	_	_
18-16	2069-2070	.	_	_	_	_

#Text=Other enzymes released include leucine aminopeptidase , collagenase and chymotrypsin-like proteases .
19-1	2071-2076	Other	substance[106]	giv[106]	coref	20-1[112_106]
19-2	2077-2084	enzymes	substance[106]	giv[106]	_	_
19-3	2085-2093	released	_	_	_	_
19-4	2094-2101	include	_	_	_	_
19-5	2102-2109	leucine	substance|substance[108]	new|new[108]	_	_
19-6	2110-2124	aminopeptidase	substance[108]	new[108]	_	_
19-7	2125-2126	,	_	_	_	_
19-8	2127-2138	collagenase	object	new	coref	25-1
19-9	2139-2142	and	_	_	_	_
19-10	2143-2160	chymotrypsin-like	abstract|object[111]	new|new[111]	_	_
19-11	2161-2170	proteases	object[111]	new[111]	_	_
19-12	2171-2172	.	_	_	_	_

#Text=These enzymes have various functions in the wound ; they mainly transform dead tissue into liquid , which is either exuded from the wound or consumed by the maggots .
20-1	2173-2178	These	substance[112]	giv[112]	coref	24-17[153_112]
20-2	2179-2186	enzymes	substance[112]	giv[112]	_	_
20-3	2187-2191	have	_	_	_	_
20-4	2192-2199	various	abstract[113]	new[113]	ana	20-10[0_113]
20-5	2200-2209	functions	abstract[113]	new[113]	_	_
20-6	2210-2212	in	abstract[113]	new[113]	_	_
20-7	2213-2216	the	abstract[113]|abstract[114]	new[113]|giv[114]	coref	20-23[118_114]
20-8	2217-2222	wound	abstract[113]|abstract[114]	new[113]|giv[114]	_	_
20-9	2223-2224	;	_	_	_	_
20-10	2225-2229	they	abstract	giv	_	_
20-11	2230-2236	mainly	_	_	_	_
20-12	2237-2246	transform	_	_	_	_
20-13	2247-2251	dead	object[116]	giv[116]	coref	27-8[0_116]
20-14	2252-2258	tissue	object[116]	giv[116]	_	_
20-15	2259-2263	into	_	_	_	_
20-16	2264-2270	liquid	substance	new	_	_
20-17	2271-2272	,	_	_	_	_
20-18	2273-2278	which	_	_	_	_
20-19	2279-2281	is	_	_	_	_
20-20	2282-2288	either	_	_	_	_
20-21	2289-2295	exuded	_	_	_	_
20-22	2296-2300	from	_	_	_	_
20-23	2301-2304	the	abstract[118]	giv[118]	coref	23-20[0_118]
20-24	2305-2310	wound	abstract[118]	giv[118]	_	_
20-25	2311-2313	or	_	_	_	_
20-26	2314-2322	consumed	_	_	_	_
20-27	2323-2325	by	_	_	_	_
20-28	2326-2329	the	animal[119]	giv[119]	_	_
20-29	2330-2337	maggots	animal[119]	giv[119]	_	_
20-30	2338-2339	.	_	_	_	_

#Text=The evacuation of necrosis and reduction in bacterial contamination promotes the regeneration process .
21-1	2340-2343	The	event[120]	new[120]	_	_
21-2	2344-2354	evacuation	event[120]	new[120]	_	_
21-3	2355-2357	of	event[120]	new[120]	_	_
21-4	2358-2366	necrosis	event[120]|abstract	new[120]|giv	coref	26-2
21-5	2367-2370	and	event[120]	new[120]	_	_
21-6	2371-2380	reduction	event[120]|abstract[122]	new[120]|new[122]	_	_
21-7	2381-2383	in	event[120]|abstract[122]	new[120]|new[122]	_	_
21-8	2384-2393	bacterial	event[120]|abstract[122]|substance[123]	new[120]|new[122]|new[123]	_	_
21-9	2394-2407	contamination	event[120]|abstract[122]|substance[123]	new[120]|new[122]|new[123]	_	_
21-10	2408-2416	promotes	_	_	_	_
21-11	2417-2420	the	abstract[125]	giv[125]	coref	22-17[131_125]
21-12	2421-2433	regeneration	abstract|abstract[125]	new|giv[125]	coref	26-31[175_0]
21-13	2434-2441	process	abstract[125]	giv[125]	_	_
21-14	2442-2443	.	_	_	_	_

#Text=The authors of numerous recently published papers have noted chemical substances that influence the promotion of the healing process .
22-1	2444-2447	The	person[126]	new[126]	_	_
22-2	2448-2455	authors	person[126]	new[126]	_	_
22-3	2456-2458	of	person[126]	new[126]	_	_
22-4	2459-2467	numerous	person[126]|object[127]	new[126]|new[127]	_	_
22-5	2468-2476	recently	person[126]|object[127]	new[126]|new[127]	_	_
22-6	2477-2486	published	person[126]|object[127]	new[126]|new[127]	_	_
22-7	2487-2493	papers	person[126]|object[127]	new[126]|new[127]	_	_
22-8	2494-2498	have	_	_	_	_
22-9	2499-2504	noted	_	_	_	_
22-10	2505-2513	chemical	substance[128]	new[128]	_	_
22-11	2514-2524	substances	substance[128]	new[128]	_	_
22-12	2525-2529	that	_	_	_	_
22-13	2530-2539	influence	_	_	_	_
22-14	2540-2543	the	abstract[129]	new[129]	_	_
22-15	2544-2553	promotion	abstract[129]	new[129]	_	_
22-16	2554-2556	of	abstract[129]	new[129]	_	_
22-17	2557-2560	the	abstract[129]|abstract[131]	new[129]|giv[131]	_	_
22-18	2561-2568	healing	abstract[129]|object|abstract[131]	new[129]|giv|giv[131]	coref	23-32[145_0]
22-19	2569-2576	process	abstract[129]|abstract[131]	new[129]|giv[131]	_	_
22-20	2577-2578	.	_	_	_	_

#Text=The migration of resident epidermal keratinocytes and dermal cells , including fibroblasts and dermal microvascular cells , from the wound margins into the wound bed , is a crucial step in wound healing .
23-1	2579-2582	The	abstract[132]	new[132]	coref	23-28[143_132]
23-2	2583-2592	migration	abstract[132]	new[132]	_	_
23-3	2593-2595	of	abstract[132]	new[132]	_	_
23-4	2596-2604	resident	abstract[132]|object[133]	new[132]|new[133]	_	_
23-5	2605-2614	epidermal	abstract[132]|object[133]	new[132]|new[133]	_	_
23-6	2615-2628	keratinocytes	abstract[132]|object[133]	new[132]|new[133]	_	_
23-7	2629-2632	and	abstract[132]	new[132]	_	_
23-8	2633-2639	dermal	abstract[132]|animal|object[135]	new[132]|new|new[135]	coref|coref	23-14|23-14
23-9	2640-2645	cells	abstract[132]|object[135]	new[132]|new[135]	_	_
23-10	2646-2647	,	abstract[132]	new[132]	_	_
23-11	2648-2657	including	abstract[132]	new[132]	_	_
23-12	2658-2669	fibroblasts	abstract[132]|object	new[132]|new	_	_
23-13	2670-2673	and	abstract[132]	new[132]	_	_
23-14	2674-2680	dermal	abstract[132]|animal|object[138]	new[132]|giv|new[138]	coref|coref	24-36[158_138]|24-36[158_138]
23-15	2681-2694	microvascular	abstract[132]|object[138]	new[132]|new[138]	_	_
23-16	2695-2700	cells	abstract[132]|object[138]	new[132]|new[138]	_	_
23-17	2701-2702	,	abstract[132]	new[132]	_	_
23-18	2703-2707	from	abstract[132]	new[132]	_	_
23-19	2708-2711	the	abstract[132]|place[140]	new[132]|new[140]	_	_
23-20	2712-2717	wound	abstract[132]|abstract|place[140]	new[132]|giv|new[140]	coref	23-24
23-21	2718-2725	margins	abstract[132]|place[140]	new[132]|new[140]	_	_
23-22	2726-2730	into	abstract[132]|place[140]	new[132]|new[140]	_	_
23-23	2731-2734	the	abstract[132]|place[140]|place[142]	new[132]|new[140]|giv[142]	_	_
23-24	2735-2740	wound	abstract[132]|place[140]|abstract|place[142]	new[132]|new[140]|giv|giv[142]	coref	23-32
23-25	2741-2744	bed	abstract[132]|place[140]|place[142]	new[132]|new[140]|giv[142]	_	_
23-26	2745-2746	,	_	_	_	_
23-27	2747-2749	is	_	_	_	_
23-28	2750-2751	a	abstract[143]	giv[143]	ana	24-21[0_143]
23-29	2752-2759	crucial	abstract[143]	giv[143]	_	_
23-30	2760-2764	step	abstract[143]	giv[143]	_	_
23-31	2765-2767	in	abstract[143]	giv[143]	_	_
23-32	2768-2773	wound	abstract[143]|abstract|object[145]	giv[143]|giv|giv[145]	coref|coref|coref|coref	26-11[0_145]|31-4[219_0]|26-11[0_145]|31-4[219_0]
23-33	2774-2781	healing	abstract[143]|object[145]	giv[143]|giv[145]	_	_
23-34	2782-2783	.	_	_	_	_

#Text=Amino acids , such as L-histidine , 3-guanidinopropionic acid and L-valinol , have been identified in larva secretions , and it has been demonstrated in vitro that these isolated components specifically increase the proliferation of human endothelial cells .
24-1	2784-2789	Amino	object|substance[147]	new|new[147]	_	_
24-2	2790-2795	acids	substance[147]	new[147]	_	_
24-3	2796-2797	,	substance[147]	new[147]	_	_
24-4	2798-2802	such	substance[147]	new[147]	_	_
24-5	2803-2805	as	substance[147]	new[147]	_	_
24-6	2806-2817	L-histidine	substance[147]|substance	new[147]|new	_	_
24-7	2818-2819	,	substance[147]	new[147]	_	_
24-8	2820-2840	3-guanidinopropionic	substance[147]|abstract|substance[150]	new[147]|new|new[150]	_	_
24-9	2841-2845	acid	substance[147]|substance[150]	new[147]|new[150]	_	_
24-10	2846-2849	and	substance[147]	new[147]	_	_
24-11	2850-2859	L-valinol	substance[147]|substance	new[147]|new	_	_
24-12	2860-2861	,	_	_	_	_
24-13	2862-2866	have	_	_	_	_
24-14	2867-2871	been	_	_	_	_
24-15	2872-2882	identified	_	_	_	_
24-16	2883-2885	in	_	_	_	_
24-17	2886-2891	larva	animal|substance[153]	new|giv[153]	coref|coref	25-19[165_153]|25-19[165_153]
24-18	2892-2902	secretions	substance[153]	giv[153]	_	_
24-19	2903-2904	,	_	_	_	_
24-20	2905-2908	and	_	_	_	_
24-21	2909-2911	it	abstract	giv	_	_
24-22	2912-2915	has	_	_	_	_
24-23	2916-2920	been	_	_	_	_
24-24	2921-2933	demonstrated	_	_	_	_
24-25	2934-2936	in	_	_	_	_
24-26	2937-2942	vitro	_	_	_	_
24-27	2943-2947	that	_	_	_	_
24-28	2948-2953	these	abstract[155]	new[155]	coref	25-13[164_155]
24-29	2954-2962	isolated	abstract[155]	new[155]	_	_
24-30	2963-2973	components	abstract[155]	new[155]	_	_
24-31	2974-2986	specifically	_	_	_	_
24-32	2987-2995	increase	_	_	_	_
24-33	2996-2999	the	event[156]	new[156]	_	_
24-34	3000-3013	proliferation	event[156]	new[156]	_	_
24-35	3014-3016	of	event[156]	new[156]	_	_
24-36	3017-3022	human	event[156]|object[158]	new[156]|giv[158]	_	_
24-37	3023-3034	endothelial	event[156]|object|object[158]	new[156]|new|giv[158]	_	_
24-38	3035-3040	cells	event[156]|object[158]	new[156]|giv[158]	_	_
24-39	3041-3042	.	_	_	_	_

#Text=Collagenase speeds up the process of proteolysis by decomposing the material into smaller components , digested later by other enzymes secreted by the larvae .
25-1	3043-3054	Collagenase	substance|abstract[160]	giv|new[160]	appos|appos	25-4[161_160]|25-4[161_160]
25-2	3055-3061	speeds	abstract[160]	new[160]	_	_
25-3	3062-3064	up	abstract[160]	new[160]	_	_
25-4	3065-3068	the	abstract[161]	giv[161]	_	_
25-5	3069-3076	process	abstract[161]	giv[161]	_	_
25-6	3077-3079	of	abstract[161]	giv[161]	_	_
25-7	3080-3091	proteolysis	abstract[161]|substance	giv[161]|new	_	_
25-8	3092-3094	by	_	_	_	_
25-9	3095-3106	decomposing	_	_	_	_
25-10	3107-3110	the	substance[163]	new[163]	_	_
25-11	3111-3119	material	substance[163]	new[163]	_	_
25-12	3120-3124	into	_	_	_	_
25-13	3125-3132	smaller	abstract[164]	giv[164]	_	_
25-14	3133-3143	components	abstract[164]	giv[164]	_	_
25-15	3144-3145	,	_	_	_	_
25-16	3146-3154	digested	_	_	_	_
25-17	3155-3160	later	_	_	_	_
25-18	3161-3163	by	_	_	_	_
25-19	3164-3169	other	substance[165]	giv[165]	coref	33-12[230_165]
25-20	3170-3177	enzymes	substance[165]	giv[165]	_	_
25-21	3178-3186	secreted	_	_	_	_
25-22	3187-3189	by	_	_	_	_
25-23	3190-3193	the	animal[166]	giv[166]	coref	28-9[0_166]
25-24	3194-3200	larvae	animal[166]	giv[166]	_	_
25-25	3201-3202	.	_	_	_	_

#Text=Once necrosis is effectively removed , the consecutive stages of healing are facilitated by the increased phagocytic activity of leukocytes and higher oxygen pressure , resulting in optimum conditions for the regeneration of damaged tissues .
26-1	3203-3207	Once	_	_	_	_
26-2	3208-3216	necrosis	event	giv	_	_
26-3	3217-3219	is	_	_	_	_
26-4	3220-3231	effectively	_	_	_	_
26-5	3232-3239	removed	_	_	_	_
26-6	3240-3241	,	_	_	_	_
26-7	3242-3245	the	event[168]	new[168]	_	_
26-8	3246-3257	consecutive	event[168]	new[168]	_	_
26-9	3258-3264	stages	event[168]	new[168]	_	_
26-10	3265-3267	of	event[168]	new[168]	_	_
26-11	3268-3275	healing	event[168]|object	new[168]|giv	_	_
26-12	3276-3279	are	_	_	_	_
26-13	3280-3291	facilitated	_	_	_	_
26-14	3292-3294	by	_	_	_	_
26-15	3295-3298	the	abstract[170]	new[170]	_	_
26-16	3299-3308	increased	abstract[170]	new[170]	_	_
26-17	3309-3319	phagocytic	abstract[170]	new[170]	_	_
26-18	3320-3328	activity	abstract[170]	new[170]	_	_
26-19	3329-3331	of	abstract[170]	new[170]	_	_
26-20	3332-3342	leukocytes	abstract[170]|substance	new[170]|new	_	_
26-21	3343-3346	and	abstract[170]	new[170]	_	_
26-22	3347-3353	higher	abstract[170]|abstract[173]	new[170]|new[173]	coref	36-5[0_173]
26-23	3354-3360	oxygen	abstract[170]|substance|abstract[173]	new[170]|new|new[173]	_	_
26-24	3361-3369	pressure	abstract[170]|abstract[173]	new[170]|new[173]	_	_
26-25	3370-3371	,	_	_	_	_
26-26	3372-3381	resulting	_	_	_	_
26-27	3382-3384	in	_	_	_	_
26-28	3385-3392	optimum	abstract[174]	new[174]	_	_
26-29	3393-3403	conditions	abstract[174]	new[174]	_	_
26-30	3404-3407	for	abstract[174]	new[174]	_	_
26-31	3408-3411	the	abstract[174]|abstract[175]	new[174]|giv[175]	_	_
26-32	3412-3424	regeneration	abstract[174]|abstract[175]	new[174]|giv[175]	_	_
26-33	3425-3427	of	abstract[174]|abstract[175]	new[174]|giv[175]	_	_
26-34	3428-3435	damaged	abstract[174]|abstract[175]|object[176]	new[174]|giv[175]|new[176]	_	_
26-35	3436-3443	tissues	abstract[174]|abstract[175]|object[176]	new[174]|giv[175]|new[176]	_	_
26-36	3444-3445	.	_	_	_	_

#Text=Proteolytic digestion is the initial act of tissue repair , leading to hemostasis , thrombosis , inflammatory cell activation and the reconstruction of tissue .
27-1	3446-3457	Proteolytic	abstract[177]	new[177]	coref	27-4[178_177]
27-2	3458-3467	digestion	abstract[177]	new[177]	_	_
27-3	3468-3470	is	_	_	_	_
27-4	3471-3474	the	abstract[178]	giv[178]	_	_
27-5	3475-3482	initial	abstract[178]	giv[178]	_	_
27-6	3483-3486	act	abstract[178]	giv[178]	_	_
27-7	3487-3489	of	abstract[178]	giv[178]	_	_
27-8	3490-3496	tissue	abstract[178]|object|abstract[180]	giv[178]|giv|new[180]	coref|coref	27-24|27-24
27-9	3497-3503	repair	abstract[178]|abstract[180]	giv[178]|new[180]	_	_
27-10	3504-3505	,	_	_	_	_
27-11	3506-3513	leading	_	_	_	_
27-12	3514-3516	to	_	_	_	_
27-13	3517-3527	hemostasis	substance	new	_	_
27-14	3528-3529	,	_	_	_	_
27-15	3530-3540	thrombosis	event	new	_	_
27-16	3541-3542	,	_	_	_	_
27-17	3543-3555	inflammatory	event[184]	new[184]	_	_
27-18	3556-3560	cell	place|event[184]	new|new[184]	_	_
27-19	3561-3571	activation	event[184]	new[184]	_	_
27-20	3572-3575	and	_	_	_	_
27-21	3576-3579	the	event[185]	new[185]	_	_
27-22	3580-3594	reconstruction	event[185]	new[185]	_	_
27-23	3595-3597	of	event[185]	new[185]	_	_
27-24	3598-3604	tissue	event[185]|object	new[185]|giv	coref	33-1[228_0]
27-25	3605-3606	.	_	_	_	_

#Text=Several studies suggest that the beneficial effect of larvae may be due to their ability to reduce pro-inflammatory factors .
28-1	3607-3614	Several	abstract[187]	new[187]	_	_
28-2	3615-3622	studies	abstract[187]	new[187]	_	_
28-3	3623-3630	suggest	_	_	_	_
28-4	3631-3635	that	_	_	_	_
28-5	3636-3639	the	abstract[188]	new[188]	_	_
28-6	3640-3650	beneficial	abstract[188]	new[188]	_	_
28-7	3651-3657	effect	abstract[188]	new[188]	_	_
28-8	3658-3660	of	abstract[188]	new[188]	_	_
28-9	3661-3667	larvae	abstract[188]|animal	new[188]|giv	ana	28-14
28-10	3668-3671	may	_	_	_	_
28-11	3672-3674	be	_	_	_	_
28-12	3675-3678	due	_	_	_	_
28-13	3679-3681	to	_	_	_	_
28-14	3682-3687	their	animal|abstract[191]	giv|new[191]	_	_
28-15	3688-3695	ability	abstract[191]	new[191]	_	_
28-16	3696-3698	to	_	_	_	_
28-17	3699-3705	reduce	_	_	_	_
28-18	3706-3722	pro-inflammatory	abstract[192]	new[192]	coref	34-7[235_192]
28-19	3723-3730	factors	abstract[192]	new[192]	_	_
28-20	3731-3732	.	_	_	_	_

#Text=The work of Pecivova et al. studied the effect of the Lucilia sericata salivary gland extract on opsonized neutrophils , stimulated with zymogen and unstimulated neutrophils .
29-1	3733-3736	The	abstract[193]	new[193]	_	_
29-2	3737-3741	work	abstract[193]	new[193]	_	_
29-3	3742-3744	of	abstract[193]	new[193]	_	_
29-4	3745-3753	Pecivova	abstract[193]|person	new[193]|new	_	_
29-5	3754-3756	et	abstract[193]	new[193]	_	_
29-6	3757-3760	al.	abstract[193]	new[193]	_	_
29-7	3761-3768	studied	_	_	_	_
29-8	3769-3772	the	abstract[195]	new[195]	coref	30-5[204_195]
29-9	3773-3779	effect	abstract[195]	new[195]	_	_
29-10	3780-3782	of	abstract[195]	new[195]	_	_
29-11	3783-3786	the	abstract[195]	new[195]	_	_
29-12	3787-3794	Lucilia	abstract[195]	new[195]	_	_
29-13	3795-3803	sericata	abstract[195]	new[195]	_	_
29-14	3804-3812	salivary	abstract[195]|substance[197]	new[195]|new[197]	coref	30-1[203_197]
29-15	3813-3818	gland	abstract[195]|substance|substance[197]	new[195]|new|new[197]	coref	30-2
29-16	3819-3826	extract	abstract[195]|substance[197]	new[195]|new[197]	_	_
29-17	3827-3829	on	abstract[195]|substance[197]	new[195]|new[197]	_	_
29-18	3830-3839	opsonized	abstract[195]|substance[197]|object[198]	new[195]|new[197]|new[198]	coref	29-25[200_198]
29-19	3840-3851	neutrophils	abstract[195]|substance[197]|object[198]	new[195]|new[197]|new[198]	_	_
29-20	3852-3853	,	_	_	_	_
29-21	3854-3864	stimulated	_	_	_	_
29-22	3865-3869	with	_	_	_	_
29-23	3870-3877	zymogen	substance	new	_	_
29-24	3878-3881	and	_	_	_	_
29-25	3882-3894	unstimulated	object[200]	giv[200]	coref	30-14[210_200]
29-26	3895-3906	neutrophils	object[200]	giv[200]	_	_
29-27	3907-3908	.	_	_	_	_

#Text=Salivary gland extract had no effect on superoxide production and myeloperoxidase release from unstimulated neutrophils , but significantly reduced both peroxide production and MPO secretion levels in zsonogen-stimulated opsonized neutrophils .
30-1	3909-3917	Salivary	substance|substance[203]	new|giv[203]	_	_
30-2	3918-3923	gland	substance|substance[203]	giv|giv[203]	_	_
30-3	3924-3931	extract	substance[203]	giv[203]	_	_
30-4	3932-3935	had	_	_	_	_
30-5	3936-3938	no	abstract[204]	giv[204]	_	_
30-6	3939-3945	effect	abstract[204]	giv[204]	_	_
30-7	3946-3948	on	abstract[204]	giv[204]	_	_
30-8	3949-3959	superoxide	abstract[204]|substance|abstract[206]|abstract[207]	giv[204]|new|new[206]|new[207]	coref|coref|coref|coref|coref|coref	30-20[212_206]|30-20[213_207]|30-20[212_206]|30-20[213_207]|30-20[212_206]|30-20[213_207]
30-9	3960-3970	production	abstract[204]|abstract[206]|abstract[207]	giv[204]|new[206]|new[207]	_	_
30-10	3971-3974	and	abstract[204]|abstract[207]	giv[204]|new[207]	_	_
30-11	3975-3990	myeloperoxidase	abstract[204]|abstract[207]|abstract|event[209]	giv[204]|new[207]|new|new[209]	_	_
30-12	3991-3998	release	abstract[204]|abstract[207]|event[209]	giv[204]|new[207]|new[209]	_	_
30-13	3999-4003	from	abstract[204]|abstract[207]|event[209]	giv[204]|new[207]|new[209]	_	_
30-14	4004-4016	unstimulated	abstract[204]|abstract[207]|event[209]|object[210]	giv[204]|new[207]|new[209]|giv[210]	coref	30-28[217_210]
30-15	4017-4028	neutrophils	abstract[204]|abstract[207]|event[209]|object[210]	giv[204]|new[207]|new[209]|giv[210]	_	_
30-16	4029-4030	,	_	_	_	_
30-17	4031-4034	but	_	_	_	_
30-18	4035-4048	significantly	_	_	_	_
30-19	4049-4056	reduced	_	_	_	_
30-20	4057-4061	both	abstract[212]|abstract[213]	giv[212]|giv[213]	_	_
30-21	4062-4070	peroxide	substance|abstract[212]|abstract[213]	new|giv[212]|giv[213]	_	_
30-22	4071-4081	production	abstract[212]|abstract[213]	giv[212]|giv[213]	_	_
30-23	4082-4085	and	abstract[213]	giv[213]	_	_
30-24	4086-4089	MPO	abstract[213]|substance|abstract[216]	giv[213]|new|new[216]	_	_
30-25	4090-4099	secretion	abstract[213]|abstract|abstract[216]	giv[213]|new|new[216]	_	_
30-26	4100-4106	levels	abstract[213]|abstract[216]	giv[213]|new[216]	_	_
30-27	4107-4109	in	abstract[213]|abstract[216]	giv[213]|new[216]	_	_
30-28	4110-4129	zsonogen-stimulated	abstract[213]|abstract[216]|object[217]	giv[213]|new[216]|giv[217]	_	_
30-29	4130-4139	opsonized	abstract[213]|abstract[216]|object[217]	giv[213]|new[216]|giv[217]	_	_
30-30	4140-4151	neutrophils	abstract[213]|abstract[216]|object[217]	giv[213]|new[216]|giv[217]	_	_
30-31	4152-4153	.	_	_	_	_

#Text=Following debridement , the wound may be appropriately assessed .
31-1	4154-4163	Following	_	_	_	_
31-2	4164-4175	debridement	event	giv	_	_
31-3	4176-4177	,	_	_	_	_
31-4	4178-4181	the	abstract[219]	giv[219]	coref	32-13[0_219]
31-5	4182-4187	wound	abstract[219]	giv[219]	_	_
31-6	4188-4191	may	_	_	_	_
31-7	4192-4194	be	_	_	_	_
31-8	4195-4208	appropriately	_	_	_	_
31-9	4209-4217	assessed	_	_	_	_
31-10	4218-4219	.	_	_	_	_

#Text=Consequently , it is also possible to introduce other methods that promote wound closure , or to perform a skin transplant .
32-1	4220-4232	Consequently	_	_	_	_
32-2	4233-4234	,	_	_	_	_
32-3	4235-4237	it	abstract	new	cata	32-3[0_221]
32-4	4238-4240	is	_	_	_	_
32-5	4241-4245	also	_	_	_	_
32-6	4246-4254	possible	_	_	_	_
32-7	4255-4257	to	abstract[221]	new[221]	_	_
32-8	4258-4267	introduce	abstract[221]	new[221]	_	_
32-9	4268-4273	other	abstract[221]|abstract[222]	new[221]|new[222]	_	_
32-10	4274-4281	methods	abstract[221]|abstract[222]	new[221]|new[222]	_	_
32-11	4282-4286	that	_	_	_	_
32-12	4287-4294	promote	_	_	_	_
32-13	4295-4300	wound	abstract|event[224]	giv|new[224]	coref|coref	33-5[229_0]|33-5[229_0]
32-14	4301-4308	closure	event[224]	new[224]	_	_
32-15	4309-4310	,	_	_	_	_
32-16	4311-4313	or	_	_	_	_
32-17	4314-4316	to	_	_	_	_
32-18	4317-4324	perform	_	_	_	_
32-19	4325-4326	a	event[226]	new[226]	_	_
32-20	4327-4331	skin	object|event[226]	new|new[226]	_	_
32-21	4332-4342	transplant	event[226]	new[226]	_	_
32-22	4343-4344	.	_	_	_	_

#Text=The granulation tissue in the wound , debrided and stimulated by larval secretions , should be dressed as soon as possible with the chosen method of local treatment .
33-1	4345-4348	The	object[228]	giv[228]	coref	34-14[0_228]
33-2	4349-4360	granulation	abstract|object[228]	new|giv[228]	_	_
33-3	4361-4367	tissue	object[228]	giv[228]	_	_
33-4	4368-4370	in	object[228]	giv[228]	_	_
33-5	4371-4374	the	object[228]|abstract[229]	giv[228]|giv[229]	coref	34-19[0_229]
33-6	4375-4380	wound	object[228]|abstract[229]	giv[228]|giv[229]	_	_
33-7	4381-4382	,	_	_	_	_
33-8	4383-4391	debrided	_	_	_	_
33-9	4392-4395	and	_	_	_	_
33-10	4396-4406	stimulated	_	_	_	_
33-11	4407-4409	by	_	_	_	_
33-12	4410-4416	larval	substance[230]	giv[230]	_	_
33-13	4417-4427	secretions	substance[230]	giv[230]	_	_
33-14	4428-4429	,	_	_	_	_
33-15	4430-4436	should	_	_	_	_
33-16	4437-4439	be	_	_	_	_
33-17	4440-4447	dressed	_	_	_	_
33-18	4448-4450	as	_	_	_	_
33-19	4451-4455	soon	_	_	_	_
33-20	4456-4458	as	_	_	_	_
33-21	4459-4467	possible	_	_	_	_
33-22	4468-4472	with	_	_	_	_
33-23	4473-4476	the	abstract[231]	new[231]	coref	34-4[0_231]
33-24	4477-4483	chosen	abstract[231]	new[231]	_	_
33-25	4484-4490	method	abstract[231]	new[231]	_	_
33-26	4491-4493	of	abstract[231]	new[231]	_	_
33-27	4494-4499	local	abstract[231]|abstract[232]	new[231]|new[232]	_	_
33-28	4500-4509	treatment	abstract[231]|abstract[232]	new[231]|new[232]	_	_
33-29	4510-4511	.	_	_	_	_

#Text=The choice of method depends on several factors , such as level of tissue destruction , area , wound etiopathogenesis , and general condition of the patient .
34-1	4512-4515	The	abstract[233]	new[233]	_	_
34-2	4516-4522	choice	abstract[233]	new[233]	_	_
34-3	4523-4525	of	abstract[233]	new[233]	_	_
34-4	4526-4532	method	abstract[233]|abstract	new[233]|giv	_	_
34-5	4533-4540	depends	_	_	_	_
34-6	4541-4543	on	_	_	_	_
34-7	4544-4551	several	abstract[235]	giv[235]	_	_
34-8	4552-4559	factors	abstract[235]	giv[235]	_	_
34-9	4560-4561	,	abstract[235]	giv[235]	_	_
34-10	4562-4566	such	abstract[235]	giv[235]	_	_
34-11	4567-4569	as	abstract[235]	giv[235]	_	_
34-12	4570-4575	level	abstract[235]|abstract[236]	giv[235]|new[236]	_	_
34-13	4576-4578	of	abstract[235]|abstract[236]	giv[235]|new[236]	_	_
34-14	4579-4585	tissue	abstract[235]|abstract[236]|object|event[238]	giv[235]|new[236]|giv|new[238]	coref|coref	37-17[264_0]|37-17[264_0]
34-15	4586-4597	destruction	abstract[235]|abstract[236]|event[238]	giv[235]|new[236]|new[238]	_	_
34-16	4598-4599	,	abstract[235]|abstract[236]	giv[235]|new[236]	_	_
34-17	4600-4604	area	abstract[235]|abstract[236]|abstract	giv[235]|new[236]|new	_	_
34-18	4605-4606	,	abstract[235]|abstract[236]	giv[235]|new[236]	_	_
34-19	4607-4612	wound	abstract[235]|abstract[236]|abstract|abstract[241]	giv[235]|new[236]|giv|new[241]	coref|coref	36-6|36-6
34-20	4613-4629	etiopathogenesis	abstract[235]|abstract[236]|abstract[241]	giv[235]|new[236]|new[241]	_	_
34-21	4630-4631	,	abstract[235]|abstract[236]	giv[235]|new[236]	_	_
34-22	4632-4635	and	abstract[235]|abstract[236]	giv[235]|new[236]	_	_
34-23	4636-4643	general	abstract[235]|abstract[236]|abstract[242]	giv[235]|new[236]|new[242]	coref	37-27[267_242]
34-24	4644-4653	condition	abstract[235]|abstract[236]|abstract[242]	giv[235]|new[236]|new[242]	_	_
34-25	4654-4656	of	abstract[235]|abstract[236]|abstract[242]	giv[235]|new[236]|new[242]	_	_
34-26	4657-4660	the	abstract[235]|abstract[236]|abstract[242]|person[243]	giv[235]|new[236]|new[242]|new[243]	coref	37-28[266_243]
34-27	4661-4668	patient	abstract[235]|abstract[236]|abstract[242]|person[243]	giv[235]|new[236]|new[242]|new[243]	_	_
34-28	4669-4670	.	_	_	_	_

#Text=Wound management criteria should be carefully implemented based on the TIME concept .
35-1	4671-4676	Wound	person|abstract[246]	new|new[246]	_	_
35-2	4677-4687	management	organization|abstract[246]	new|new[246]	_	_
35-3	4688-4696	criteria	abstract[246]	new[246]	_	_
35-4	4697-4703	should	_	_	_	_
35-5	4704-4706	be	_	_	_	_
35-6	4707-4716	carefully	_	_	_	_
35-7	4717-4728	implemented	_	_	_	_
35-8	4729-4734	based	_	_	_	_
35-9	4735-4737	on	_	_	_	_
35-10	4738-4741	the	abstract[248]	new[248]	_	_
35-11	4742-4746	TIME	abstract|abstract[248]	new|new[248]	_	_
35-12	4747-4754	concept	abstract[248]	new[248]	_	_
35-13	4755-4756	.	_	_	_	_

#Text=The use of negative pressure wound therapy ( NPWT ) is effective in shrinking the wound , reducing exudate and bacteria , and stimulating neoangigenesis , specialized dressings , in the case of superficial and penetrative lesions that do not qualify for surgery .
36-1	4757-4760	The	abstract[249]	new[249]	_	_
36-2	4761-4764	use	abstract[249]	new[249]	_	_
36-3	4765-4767	of	abstract[249]	new[249]	_	_
36-4	4768-4776	negative	abstract[249]|event[252]	new[249]|giv[252]	_	_
36-5	4777-4785	pressure	abstract[249]|abstract|event[252]	new[249]|giv|giv[252]	_	_
36-6	4786-4791	wound	abstract[249]|abstract|event[252]	new[249]|giv|giv[252]	coref	36-15[254_0]
36-7	4792-4799	therapy	abstract[249]|event[252]	new[249]|giv[252]	_	_
36-8	4800-4801	(	_	_	_	_
36-9	4802-4806	NPWT	object	new	_	_
36-10	4807-4808	)	_	_	_	_
36-11	4809-4811	is	_	_	_	_
36-12	4812-4821	effective	_	_	_	_
36-13	4822-4824	in	_	_	_	_
36-14	4825-4834	shrinking	_	_	_	_
36-15	4835-4838	the	object[254]	giv[254]	_	_
36-16	4839-4844	wound	object[254]	giv[254]	_	_
36-17	4845-4846	,	_	_	_	_
36-18	4847-4855	reducing	_	_	_	_
36-19	4856-4863	exudate	object	giv	_	_
36-20	4864-4867	and	_	_	_	_
36-21	4868-4876	bacteria	plant	new	_	_
36-22	4877-4878	,	_	_	_	_
36-23	4879-4882	and	_	_	_	_
36-24	4883-4894	stimulating	abstract[257]	new[257]	_	_
36-25	4895-4909	neoangigenesis	abstract[257]	new[257]	_	_
36-26	4910-4911	,	_	_	_	_
36-27	4912-4923	specialized	abstract[258]	new[258]	coref	37-23[265_258]
36-28	4924-4933	dressings	abstract[258]	new[258]	_	_
36-29	4934-4935	,	_	_	_	_
36-30	4936-4938	in	_	_	_	_
36-31	4939-4942	the	_	_	_	_
36-32	4943-4947	case	_	_	_	_
36-33	4948-4950	of	_	_	_	_
36-34	4951-4962	superficial	object[259]	new[259]	_	_
36-35	4963-4966	and	object[259]	new[259]	_	_
36-36	4967-4978	penetrative	object[259]	new[259]	_	_
36-37	4979-4986	lesions	object[259]	new[259]	_	_
36-38	4987-4991	that	_	_	_	_
36-39	4992-4994	do	_	_	_	_
36-40	4995-4998	not	_	_	_	_
36-41	4999-5006	qualify	_	_	_	_
36-42	5007-5010	for	_	_	_	_
36-43	5011-5018	surgery	event	new	_	_
36-44	5019-5020	.	_	_	_	_

#Text=There are clinical situations , especially in terminally ill patients , in which wounds debrided from necrotic tissue are only managed with dressings , due to the patient ’s condition and poor prognosis .
37-1	5021-5026	There	_	_	_	_
37-2	5027-5030	are	_	_	_	_
37-3	5031-5039	clinical	abstract[261]	new[261]	_	_
37-4	5040-5050	situations	abstract[261]	new[261]	_	_
37-5	5051-5052	,	abstract[261]	new[261]	_	_
37-6	5053-5063	especially	abstract[261]|person[262]	new[261]|new[262]	_	_
37-7	5064-5066	in	abstract[261]|person[262]	new[261]|new[262]	_	_
37-8	5067-5077	terminally	abstract[261]|person[262]	new[261]|new[262]	_	_
37-9	5078-5081	ill	abstract[261]|person[262]	new[261]|new[262]	_	_
37-10	5082-5090	patients	abstract[261]|person[262]	new[261]|new[262]	_	_
37-11	5091-5092	,	_	_	_	_
37-12	5093-5095	in	_	_	_	_
37-13	5096-5101	which	_	_	_	_
37-14	5102-5108	wounds	abstract	new	_	_
37-15	5109-5117	debrided	_	_	_	_
37-16	5118-5122	from	_	_	_	_
37-17	5123-5131	necrotic	object[264]	giv[264]	_	_
37-18	5132-5138	tissue	object[264]	giv[264]	_	_
37-19	5139-5142	are	_	_	_	_
37-20	5143-5147	only	_	_	_	_
37-21	5148-5155	managed	_	_	_	_
37-22	5156-5160	with	_	_	_	_
37-23	5161-5170	dressings	abstract[265]	giv[265]	_	_
37-24	5171-5172	,	abstract[265]	giv[265]	_	_
37-25	5173-5176	due	abstract[265]	giv[265]	_	_
37-26	5177-5179	to	_	_	_	_
37-27	5180-5183	the	abstract[267]	giv[267]	_	_
37-28	5184-5191	patient	person[266]|abstract[267]	giv[266]|giv[267]	_	_
37-29	5192-5194	’s	person[266]|abstract[267]	giv[266]|giv[267]	_	_
37-30	5195-5204	condition	abstract[267]	giv[267]	_	_
37-31	5205-5208	and	_	_	_	_
37-32	5209-5213	poor	abstract[268]	new[268]	_	_
37-33	5214-5223	prognosis	abstract[268]	new[268]	_	_
37-34	5224-5225	.	_	_	_	_
